| Q24671923 | Anti-HIV agent trichosanthin enhances the capabilities of chemokines to stimulate chemotaxis and G protein activation, and this is mediated through interaction of trichosanthin and chemokine receptors |
| Q41593764 | Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors |
| Q35325810 | Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition |
| Q43764048 | Effect of phospholipid on trichosanthin adsorption at the air-water interface |
| Q36537911 | HIV/AIDS pathogenesis and treatment: new twists and turns |
| Q31110426 | Identification of the amino acid residues in trichosanthin crucial for IgE response |
| Q46756211 | Lowering of trichosanthin immunogenicity by site-specific coupling to dextran |
| Q38352475 | Modeling of the three-dimensional structure of luffin-alpha and its simulated reaction with the substrate oligoribonucleotide GAGA. |
| Q38307332 | Molecular modeling of the interactions of trichosanthin with four substrate analogs |
| Q24634681 | Pathogenesis of human immunodeficiency virus infection |
| Q40088284 | Pharmacokinetics of GLQ223 in rats, monkeys, and patients with AIDS or AIDS-related complex |
| Q74178140 | Position 120-123, a potential active site of trichosanthin |
| Q35547253 | RNase inhibition of human immunodeficiency virus infection of H9 cells |
| Q36053068 | Rapid, high-level expression of biologically active alpha-trichosanthin in transfected plants by an RNA viral vector |
| Q28363232 | Reactive oxygen species involved in trichosanthin-induced apoptosis of human choriocarcinoma cells |
| Q29301419 | Ribosome-inactivating proteins from plants: present status and future prospects |
| Q34724499 | Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex |
| Q77346577 | Site-directed polyethylene glycol modification of trichosanthin: effects on its biological activities, pharmacokinetics, and antigenicity |
| Q27730899 | The N-glycosidase mechanism of ribosome-inactivating proteins implied by crystal structures of alpha-momorcharin |
| Q74019389 | The interaction of trichosanthin with supported phospholipid membranes studied by surface plasmon resonance |
| Q41791049 | The membrane insertion of trichosanthin is membrane-surface-pH dependent |
| Q45408676 | The non-toxic A subunit of Shiga toxin type 1 prevents replication of bovine immunodeficiency virus in infected cells |
| Q40468453 | Treatment of AIDS with Drugs Targeted to Inhibit Different Stages of the HIV Life Cycle |
| Q39814166 | Trichosanthin inhibits integration of human immunodeficiency virus type 1 through depurinating the long-terminal repeats |
| Q72873810 | Trichosanthin, an initiator of the alternative complement activation pathway |
| Q58682080 | We have a prejudice against ourselves -- sentiment, ethics, and reason |